Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.49
00.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Dianthus Therapeutics (DNTH) Forecast
NewsEarningsDianthus Therapeutics (DNTH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Dianthus Therapeutics (NASDAQ:DNTH) Stock Quotes, Forecast and News Summary
Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Dianthus Therapeutics (DNTH) stock?
You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.
Who are Dianthus Therapeutics (DNTH) competitors?
Other companies in Dianthus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).
What is the forecast, or price target, for Dianthus Therapeutics (DNTH) stock?
Dianthus Therapeutics has a consensus price target of $46.43.
What is the current price for Dianthus Therapeutics (DNTH)?
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $25.49 last updated November 14, 2024 at 4:00 PM EST.
Does Dianthus Therapeutics (DNTH) pay a dividend?
There are no upcoming dividends for Dianthus Therapeutics.
When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?
Dianthus Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Dianthus Therapeutics (DNTH) going to split?
There is no upcoming split for Dianthus Therapeutics.
What sector and industry does Dianthus Therapeutics (DNTH) operate in?
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.